A detailed history of Icon Wealth Advisors, LLC transactions in Argenx Se stock. As of the latest transaction made, Icon Wealth Advisors, LLC holds 7,154 shares of ARGX stock, worth $4.57 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
7,154
Previous 510 1302.75%
Holding current value
$4.57 Million
Previous $219,000 1671.23%
% of portfolio
0.11%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$434.22 - $551.9 $2.89 Million - $3.67 Million
-6,645 Reduced 92.89%
509 $276,000
Q3 2024

Nov 12, 2024

BUY
$434.22 - $551.9 $2.88 Million - $3.67 Million
6,644 Added 1302.75%
7,154 $3.88 Million
Q2 2024

Aug 14, 2024

SELL
$356.01 - $451.55 $2,492 - $3,160
-7 Reduced 1.35%
510 $219,000
Q1 2024

May 15, 2024

BUY
$356.95 - $413.29 $61,038 - $70,672
171 Added 49.42%
517 $203,000
Q4 2023

Feb 14, 2024

BUY
$338.91 - $506.01 $117,262 - $175,079
346 New
346 $131,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $35.3B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Icon Wealth Advisors, LLC Portfolio

Follow Icon Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Icon Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Icon Wealth Advisors, LLC with notifications on news.